American Society of Hematology Annual Meeting

American Society of Hematology Annual Meeting
Name	American Society of Hematology Annual Meeting
Status	Active
Genre	Medical conference
Frequency	Annual
Venue	Varies
Location	United States and international cities
First	1958
Organizer	American Society of Hematology

American Society of Hematology Annual Meeting The American Society of Hematology Annual Meeting is the flagship annual conference of the American Society of Hematology, bringing together clinicians, researchers, and trainees from institutions such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, and Fred Hutchinson Cancer Center. The meeting serves as a primary forum for presentation of clinical trials, translational research, and practice guidelines from groups including National Institutes of Health, Food and Drug Administration, European Hematology Association, and industry partners like Roche, Novartis, Gilead Sciences. Major attendees historically include investigators affiliated with Dana-Farber Cancer Institute, Stanford University School of Medicine, University of Pennsylvania Perelman School of Medicine, and global collaborators from Karolinska Institute and University of Oxford.

History

The meeting originated in the late 1950s alongside growth at institutions such as Cleveland Clinic and Walter Reed Army Medical Center, evolving through eras marked by discoveries at Cold Spring Harbor Laboratory, regulatory milestones involving the Food and Drug Administration, and pivotal trials from cooperative groups like Children's Oncology Group and European Organisation for Research and Treatment of Cancer. Landmark topics presented have intersected with work from laboratories at Broad Institute, Salk Institute, and Institut Pasteur, and with awardees of prizes including the Lasker Award, Nobel Prize, and Gairdner Foundation International Award. The meeting adapted through technological shifts introduced by companies such as IBM and Microsoft and policy interactions with Centers for Disease Control and Prevention and World Health Organization.

Organization and Leadership

Governance and programming are overseen by boards and committees drawing leaders from Yale School of Medicine, Columbia University Irving Medical Center, UCLA Health, University of California, San Francisco, and international centers like Tokyo University Hospital and University of Toronto. Executive staff coordinate with entities such as American Board of Internal Medicine, Association of American Physicians, and partner societies including British Society for Haematology, International Society on Thrombosis and Haemostasis, and Asia-Pacific Haematology Consortium. Past presidents and program chairs have held appointments at University of Chicago Medical Center, NewYork-Presbyterian Hospital, Emory University Hospital, and have collaborated with funders such as Bill & Melinda Gates Foundation and Howard Hughes Medical Institute.

Program and Scientific Content

Scientific content spans plenaries, oral presentations, poster sessions, and workshops featuring investigators from Harvard Medical School, Imperial College London, Monash University, Weill Cornell Medicine, and consortia including European LeukemiaNet, Beat AML Master Trial, and Genentech-sponsored studies. Topics include translational work on targets characterized at Cold Spring Harbor Laboratory, genomics contributions from Wellcome Sanger Institute and European Molecular Biology Laboratory, and therapeutics developed by Bristol Myers Squibb, Amgen, Pfizer, and AstraZeneca. Protocols and guideline updates often reference trials by Intergroup Trialists, meta-analyses from Cochrane Collaboration, and registries maintained by Surveillance, Epidemiology, and End Results Program.

Attendance and Impact

Typical attendance draws physician-scientists, trainees, and industry delegates from venues such as Las Vegas Convention Center, Hynes Convention Center, McCormick Place, San Diego Convention Center, and international sites like ExCeL London and Melbourne Convention and Exhibition Centre. The meeting influences practice at hospitals including Cleveland Clinic Florida, St. Jude Children's Research Hospital, King's College Hospital, Sheba Medical Center, and regulatory decisions by European Medicines Agency as well as Pharmaceutical Research and Manufacturers of America. Citation impact links research presented to journals such as New England Journal of Medicine, The Lancet, Blood (journal), Journal of Clinical Oncology, and Nature Medicine.

Awards and Recognitions

Awards conferred at the meeting honor contributions recognized by bodies such as American Society of Clinical Oncology, Royal Society, American Association for Cancer Research, and include named prizes reflecting legacies at Stanford University, University of Michigan, Duke University, Johns Hopkins University, and Vanderbilt University Medical Center. Recipients often include investigators affiliated with Memorial Sloan Kettering Cancer Center and grantees of National Cancer Institute and European Research Council. The meeting also presents trainee awards sponsored by organizations like American Medical Association and fellowships tied to Fulbright Program alumni.

Notable Presentations and Controversies

High-profile presentations have reported trials led by groups at MD Anderson Cancer Center, University of Washington, University of British Columbia, and collaborations with pharmaceutical firms such as Celgene and Takeda Pharmaceutical Company. Controversies have arisen around data interpretation in trials connected to JAMA, allegations debated with oversight from Office of Research Integrity, debates about conflicts involving Pharmaceutical Research and Manufacturers of America, and policy disputes invoking guidance from Department of Health and Human Services. Ethical debates have referenced standards from Declaration of Helsinki and adjudications involving institutions like Yale New Haven Hospital.

Venue, Logistics, and Virtual Components

Logistics coordination leverages convention centers including George R. Brown Convention Center, Orange County Convention Center, and Colorado Convention Center with audiovisual and virtual platforms developed in partnership with companies such as Cisco Systems, Zoom Video Communications, and Google Cloud. Hybrid formats emerged following public health guidance from Centers for Disease Control and Prevention and global advisories by World Health Organization, enabling simultaneous sessions with abstract management systems used by Elsevier and publishing partnerships with Wiley-Blackwell and Oxford University Press.

Category:Hematology conferences